3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
5
Phase 1/2
3
Phase EARLY_PHASE1
2
Phase 1
2
Phase 4
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Urologic Diseases
1
Nephritis
1
Kidney Diseases
1
Immune System Diseases
1
Glomerulonephritis, IGA
1
Glomerulonephritis
1
Autoimmune Diseases
1
Interventions
Zoledronic Acid
15
enzalutamide
10
Leuprolide
9
Goserelin
8
bicalutamide
7
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
6
Triptorelin Pamoate
6
Prednisone
6
Nivolumab
6
Abiraterone Acetate
6
luprolide acetate gel depot
5
Sunitinib
5
Magnetic Resonance Spectroscopy
5
Everolimus
5
Dutasteride
5
Specimen Handling
4
Sodium Chloride
4
Propofol
4
Prednisolone
4
Androgen Antagonists
4
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
4
pazopanib
3
fluciclovine F-18
3
darolutamide
3
cabazitaxel
3
Trimethoprim, Sulfamethoxazole Drug Combination
3
Rocuronium
3
Mitomycin
3
Midazolam
3
Flutamide
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Hydroxychloroquine
×
Genitourinary
×
Clear all
NCT02765594
2017-09-20
HCQIgAN
Peking Union Medical College Hospital
Phase 4
Unknown
98 enrolled